Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SE-7552 | 2243575-79-1 | 99.5% | 335.28 | 1 ML
SDP

Supplier:  Medchemexpress LLC HY16130510MM/1ML

Encompass_Preferred

SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. It demonstrates greater than 850-fold selectivity versus all other known HDAC isozymes. This compound is capable of blocking multiple myeloma growth in vivo and acts as an anti-obesity agent in diet-induced obese mice.

  • High selectivity for HDAC6
  • Oral activity
  • Non-hydroxamate nature
  • Shown efficacy in blocking multiple myeloma growth in vivo
  • Acts as an anti-obesity agent

Catalog No. 50-003-91725


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.